Quantcast
Close Window
   
Welcome :o)
If healthcare, consumer and food products were safe, we wouldn't need a healthcare industry ;o)
 
or the FDA, CDC, ACA, NIH, etc...
 
Now THAT sure would save a shit-load of money, wouldn't it ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Hi All,
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
Thanks to all who help keep JohnsonAndToxin ad-free, online and me working to expose Johnson & Johnson and their 275+ subsidiaries for the benefit of every man, woman and child on the planet - and that INCLUDES YOU and the ones YOU love.
 
Thank you,   
Emily
 
$.00         
Glad to see you :o)
Hi All,
This is INDEPENDENT work that you are certainly NOT going to see in conventional media.
Gifts of support are always very much appreciated...
 
Thank you,
Emily
 
$.00         

Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 
Sponsored in part by...
Risperdal Boys Project Undisclosed to patients, Risperdal causes breast growth in boys.
----- / / -----
Examining Medicine An in-depth comprehensive, frequently updated look at extreme risks and permanent brain damage caused by psychiatric drugs.
----- / / -----
Fiddaman Blog Bob Fiddaman has been writing about the dangers of antidepressants since 2006. In 2011 he was presented with two human rights awards from the Citizens Commission on Human Rights.
----- / / -----
Special Needs Advocate Power Join me as we work hard to ensure what our very special children need.

JNJ 'Growth' Based on Corruption, Toxic Products, Harmful Devices and Pharma Fraud
Stock market analysts claim JNJ growth - um, but it's only an illusion based on corruption, toxic products, harmful devices and fraudulently marketed drugs.

Keywords: jnj, johnson and johnson, johnson + johnson, J&J, toxin, toxic, corruption, lawsuit
Date Created/Edited: 2013, October 24
 

Most Recent Content....
Johnson & Johnson Adds Another Two Thousand Lawsuits in Third Quarter 2017 (2017, November 17)
Lawsuits against Johnson & Johnson continue to spiral out of control - breaking over 108,000 in third quarter 2017, with numerous unmentioned products also racking up an untold number of lawsuits not mentioned in 2017 10-Q.
talc, risperdal, asr, xarelto, baby powder, tvt, mesh, lawsuit
 
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
Pharma: In the pharmacuetical segment of JNJ, they really blew up sales by increasing health risks and costs to consumers with fraudulent marketing, under-payments to health care providers and over-prescribing highly profitable drugs:
 
Nucynta: J&J painkiller probe expands scrutiny of industry marketing
J&J's Janssen unit gets federal subpoena over opioid painkiller Nucynta
 
Xarelto: FDA letter to Johnson & Johnson: "The print ad is false or misleading because it minimizes the risks associated with Xarelto and makes a misleading claim."
 
Medical Devices got a real boost from beginning the replacement of Metal-on-Metal hips around the world. The costs are not being covered by Johnson & Johnson, the costs are pushed through private pay, private insurance, Medicare, Medicaid and the public disability system. Although JNJ's faulty device replacement program is driving up health care costs and destroying economies around the world, it appears as though JNJ is profitting immensely from the distribution and replacement of KNOWN defective products.
 

Consumer Segment saw a modest increase, even with suspended products and the continued closed facility in Pennsylvania, due to chronic recalls. Recalls are highly profitable because those who purchased $3 to $10 products are more likely to toss them in the trash than return them. The products are then simply replaced creating the illusion of growth.
 
In the Toxic Products segment, JNJ is still dragging their feet on removing carcinogens and other harmful ingredients from baby care products- continuing to supply a steady supply of victims with cancer, asthma, allergies, eczema, diabetes and neurological disorders to ensure future pharmaceutical sales growth.
 
In the overall corruption department, JNJ scored again with a pathetic fine, but billions in preferential treatment, in China by violating their anti-monopoly laws. Ahh, corruption to convince people to sell and purchase faulty, inferior devices.
Chinese Court Rendered Final Judgment on Rainbow v. Johnson & Johnson – the First Antitrust Private Action of Vertical Monopolistic Agreement
 
Well, without corruption, lies, deceit, toxic products, harmful devices and fraudulently marketed drugs, JNJ would barely make any money at all, now would they? Oh, but there'd be far less human suffering - but that wouldn't be good for the stock market, would it?
 
Resources:
1. Deborah Weinstein (2013, August 6). J&J painkiller probe expands scrutiny of industry marketing Medical Marketing & Media. Retrieved from http://www.mmm-online.com/jj-painkiller-probe-expands-scrutiny-of-industry-marketing/article/306191/
 
2. David Sell (2013, August 5). J&J's Janssen unit gets federal subpoena over opioid painkiller Nucynta Philly.com. Retrieved from http://www.philly.com/philly/blogs/phillypharma/JJs-Janssen-unit-gets-federal-subpoena-over-opioid-painkiller-Nucynta.html
 
3. Zarna Patel, Pharm.D., Amy Toscano, Pharm.D., RAC, CPA (2013, June 6). WARNING LETTER United States Food and Drug Administration. Retrieved from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM357833.pdf
 
4. Emily Patterson (Section page, updated regularly with new content). Twenty Years of KNOWN Carcinogens in J&J US Baby Care Products Finally Ends! Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/products.shtml
 
5. Susan Ning, Liu Jia, Xiao Dasha and Hazel Yin (2013, August 5). Chinese Court Rendered Final Judgment on Rainbow v. Johnson & Johnson – the First Antitrust Private Action of Vertical Monopolistic Agreement China Law Insight. Retrieved from http://www.chinalawinsight.com/2013/08/articles/corporate/antitrust-competition/chinese-court-rendered-final-judgment-on-rainbow-v-johnson-johnson-the-first-antitrust-private-action-of-vertical-monopolistic-agreement/
 
 
 
 
 
 
 
 
 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries